Tweets
UPSTAND study: widespread pain responding to JAK inhibition
https://t.co/ZGouZSXaXU https://t.co/He2nXncsFF
Dr. John Cush @RheumNow ( View Tweet )
10 minutes 36 seconds ago
Who might benefit from GLP-1s in your rheumatology clinic? Join Drs. Catherine Bakewell and Leonard Calabrese at https://t.co/9THCAABeZ0, Jan 30–31 in Dallas, TX, or live online. Kick off 2027 with 12.5 CME credits. Early bird pricing through Dec 15.
https://t.co/xjuAWKqAY9 https://t.co/xhqg94lmoy
Dr. John Cush @RheumNow ( View Tweet )
4 hours ago
Pioneers & Progress in Pediatric Rheumatology: The 50th Anniversary
Dr. Susan Shenoi | "Mastering the Field of Pediatric Rheumatology: Pioneers and Progress, 50th Anniversary" |ACR 2026
https://t.co/hSx8LHR99s https://t.co/cQNLQkT6qp
Dr. John Cush @RheumNow ( View Tweet )
5 hours 10 minutes ago
Not All Pain in Rheumatic Disease is Inflammatory
In a session at the Global Rheumatology Summit, Dr. Daniel Clauw, an expert on the topic, explained that fibromyalgia can occur in isolation in a “top-down” fashion, or can be secondary to inflammatory autoimmune diseases in a https://t.co/AMUm52SKsB
Dr. John Cush @RheumNow ( View Tweet )
7 hours 10 minutes ago
Points to Consider in D2M/Treatment Refractory axSpA
New ASAS guidance presented at #ACR26 outlines 10 points to consider, from diagnostic reassessment to inflammation, mimics & treatment adherence.
Dr. Sheila Reyes breaks it down: https://t.co/vvT2qWbbM7 https://t.co/Crf5uisIvS
Dr. John Cush @RheumNow ( View Tweet )
9 hours 8 minutes ago
To Pulse or Not to Pulse in ANCA Associated Vasculitis?
New #ACR26 data found no significant remission benefit with pulse steroids, but serious infections were higher (31% vs 14%). Is it time to rethink their use?
Dr. Michael Putman weighs in: https://t.co/b6cJkI2aXc https://t.co/rM3eoRBJYW
Dr. John Cush @RheumNow ( View Tweet )
20 hours 10 minutes ago
What does CAR-T safety look like between autoimmune disease and heme-onc?
Here's CRS and ICANS within the cohorts so far
(although don't forget about the lymphodepletion)
Anca Askanase @HSpecialSurgery #ACR26 @RheumNow https://t.co/GkDGDiOET4
David Liew @drdavidliew ( View Tweet )
21 hours 4 minutes ago
Two Prescriptions, One Patient
Obesity, in particular in PsA was widely covered at #ACR26. In the Swiss SCQM registry, 63.6% of 2,087 patients with PsA were overweight or obese, compared with 31% overweight and 12% obese in the Swiss population, and higher BMI tracked disease https://t.co/Ys5wTvQ2r9
Dr. John Cush @RheumNow ( View Tweet )
21 hours 10 minutes ago
ACR 2026 Day 4 Report
The last day of ACR 2026 was a half-day but a busy day, with several exciting reports, especially coming from the late-breaking abstracts.
https://t.co/wBfrQhwZHy https://t.co/plZgG0Y7VN
Dr. John Cush @RheumNow ( View Tweet )
22 hours 10 minutes ago
ACR 2026: RA Topic Panel https://t.co/4Jttct8XKe
Links:
Dr. John Cush @RheumNow ( View Tweet )
22 hours 10 minutes ago
TRBV9+ a novel treatment approach for AxSpA?
https://t.co/sNV9KsgvNa https://t.co/b6fRnwdLYf
Dr. John Cush @RheumNow ( View Tweet )
22 hours 40 minutes ago
Check the genetics in your patients with ILD
A common misconception is that genetic variants don’t cause disease in adults, says Dr. Korf. According to Dr. Bogunovic, 1 in 4 adults will have a first manifestation of genetic error of immunity in adulthood. Genetics seems to be https://t.co/qRUV0oiu0a
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
T-Cell Engagers in Autoimmunity: CRS From 12% to 67% Across Six Reports
Six ACR 2026 reports put BCMA, CD19, CD20 and gamma-delta engagers side by side in autoimmune disease. The efficacy signal is consistent. The safety signal depends almost entirely on how the molecule was https://t.co/PHm1fF3Tg4
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Cardiovascular Risk in Axial Spondyloarthritis
When a patient with axial spondyloarthritis patient sits in your clinic, their joint inflammation is only half the story. To truly achieve disease control, one should ask: “Am I consistently and aggressively screening them all for https://t.co/t0hLcKIowz
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
CAR T Gets the Spotlight. Are We Missing the B Cells That Matter?
CAR T is having its moment in rheumatology. But William Robinson’s presentation at ACR Convergence 2026 raised a question I find even more compelling: are we failing to eliminate the right B cells with therapies https://t.co/uta77oaayo
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
